Page 2 - Les Meilleurs doctors pour le traitement de cancer des ovaires à Istanbul - TOP-26 des médecins

Le professeur Cemil Bilir allie expertise clinique et recherche avancée, travaillant à l'Université de Sakarya et à l'hôpital VM Medical Park Pendik.

• Spécialisé en oncologie médicale avec plus de 15 ans d'expérience
• Formé à la Cleveland Clinic et à la Northeastern University aux États-Unis
• Membre actif de l'ASCO, de l'ESMO et de la TTOD
• Poursuit actuellement un doctorat en chimie inorganique

Plus de 900 interventions réalisées – Le Dr Yalcinkaya est spécialisé en oncologie gynécologique au centre médical Anadolu.

• 19 ans d'expérience en gynécologie et oncologie gynécologique
• Professeur agrégé spécialisé dans les cas de cancer de l'ovaire
• Membre d'une équipe d'oncologie multidisciplinaire pour des soins complets
• Évalué 4,6 par les patients pour la qualité des soins

Spécialisé en chirurgie oncologique gynécologique et en chirurgie laparoscopique – Le Dr Karakas se concentre sur les techniques mini-invasives pour le cancer de l'ovaire à l'hôpital Hisar Intercontinental.

• Expert en chirurgie sans cicatrice V-Notes pour l'ablation de l'utérus et des kystes
• Réaliser des procédures laparoscopiques avancées pour les cancers gynécologiques
• Formation spécialisée en chirurgie oncologique et traitements du plancher pelvien
• Mettre l'accent sur la préservation de la fertilité lorsque cela est possible dans les cas de cancer

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.